NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.

Author(s): Mengod G, Charli JL, Palacios JM

Publication: Cell Mol Neurobiol, 1990, Vol. 10, Page 113-26

PubMed ID: 2334944 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to examine the effect of postmortem interval (PMI), patient age, gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by in situ hybridization (ISH) and northern blot.

Conclusion of Paper

No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.

Studies

  1. Study Purpose

    The purpose of this study was to examine the effect of PMI (5.5-15 h), patient age (42-82 y), gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by ISH and northern blot. Specimens from 12 control and 6 Huntington's disease patients were used for analysis.

    Summary of Findings:

    No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. Striatum allowed for observation of preproenkephalin A, somatostatin, neuropeptide Y, but not cholecystokinin, arginine-vasopressin and oxytocin. In the hypothalamus, preproenkephalin A, somatostatin, oxytocin and arginine- vasopressin were observed. Huntington's and Parkinson's disease resulted in decreased preproenkephalin A, but not somatostatin or neuropeptide Y. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Cardiovascular Disease
    • Huntington's Disease
    • Parkinson's Disease
    • Autopsy
    Platform:
    AnalyteTechnology Platform
    RNA In situ hybridization
    RNA Northern blot
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Postmortem interval 5.5 h
    6.5 h
    8.5 h
    14.5 h
    15 h
    Preaquisition Patient age 42 y
    62 y
    77 y
    82 y
    Preaquisition Patient gender Female
    Male
    Biospecimen Acquisition Biospecimen location Striatum-caudate
    Striatum-putamen
    Striatum-accumbens
    Hypothalamus
    In situ hybridization Specific Targeted nucleic acid Preproenkephalin A
    Somatostatin
    Neuropeptide Y
    Preaquisition Diagnosis/ patient condition Huntington's disease
    Parkinson's disease
    No neuropsychiatric disorder

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...